Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2026. Start Trial.
Date Value
October 02, 2026 14.52
October 01, 2026 15.55
September 30, 2026 16.72
September 29, 2026 17.37
September 28, 2026 17.65
September 25, 2026 18.22
September 24, 2026 18.54
September 23, 2026 19.72
September 22, 2026 20.60
September 21, 2026 22.24
September 18, 2026 23.23
September 17, 2026 24.82
September 16, 2026 21.64
September 15, 2026 20.84
September 14, 2026 23.41
September 11, 2026 20.89
September 10, 2026 19.90
September 09, 2026 20.89
September 08, 2026 21.92
September 04, 2026 23.27
September 03, 2026 24.68
September 02, 2026 26.04
September 01, 2026 27.49
August 31, 2026 33.60
August 28, 2026 33.11
Date Value
August 27, 2026 32.97
August 26, 2026 32.66
August 25, 2026 35.36
August 24, 2026 36.57
August 21, 2026 41.63
August 20, 2026 44.16
August 19, 2026 41.96
August 18, 2026 46.78
August 17, 2026 45.80
August 14, 2026 41.68
August 13, 2026 37.32
August 12, 2026 34.23
August 11, 2026 34.84
August 10, 2026 34.05
August 07, 2026 37.79
August 06, 2026 39.66
August 05, 2026 42.10
August 04, 2026 42.52
August 03, 2026 36.34
July 31, 2026 38.92
July 30, 2026 32.83
July 29, 2026 29.34
July 28, 2026 28.97
July 27, 2026 28.56
July 24, 2026 31.87

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
AbbVie, Inc. --
Vericel Corp. 5.552
ACADIA Pharmaceuticals, Inc. 2.628
Alnylam Pharmaceuticals, Inc. 21.70
Savara, Inc. 6.877

Price to Book Value Related Metrics

PEG Ratio -0.0035
Price 3.10
Earnings Yield -14.77%
Market Cap 84.93M
PEGY Ratio -0.0035